Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03856203 · ClinicalTrials.gov registry record
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
A clinical trial, sponsored by Boston Children's Hospital.
- Completed
- Registry status
- 12
- Enrollment target
NCT03856203: Completed study, sponsored by Boston Children's Hospital.
NCT03856203 is a clinical trial that has completed, run by Boston Children's Hospital. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03856203 has completed, sponsored by Boston Children's Hospital.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Conduct a prospective, longitudinal study to evaluate nutritional status in adults with phenylketonuria (PKU) before and during treatment with pegvaliase (Palynziq™).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2019-03-08 |
| Est. Completion | 2023-10-20 |
What the finished NCT03856203 record still lists
NCT03856203 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03856203 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03856203 about?
NCT03856203 is a clinical study titled "Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase". Conduct a prospective, longitudinal study to evaluate nutritional status in adults with phenylketonuria (PKU) before and during treatment with pegvaliase (Palynziq™).
What is the current status of trial NCT03856203?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2019-03-08. Estimated completion is 2023-10-20.
Who is sponsoring clinical trial NCT03856203?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI